Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson's disease

Hisayoshi Oka1, Masayo Morita, Kenji Onouchi

  • 1Department of Neurology, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Tokyo, 105-8461, Japan. h.oka@jikei.ac.jp

Insights

Cardiovascular autonomic dysfunction is more severe in dementia with Lewy bodies (DLB) than in Parkinson's disease (PD). This dysfunction in DLB is often due to postganglionic sympathetic nerve loss.

Area of Science:

  • Neurology
  • Cardiology

Background:

  • Cardiovascular autonomic dysfunction is a known complication in neurodegenerative diseases.
  • Dementia with Lewy bodies (DLB) and Parkinson's disease (PD) share overlapping features, necessitating differentiation of their autonomic profiles.

Purpose of the Study:

  • To compare the extent and pattern of cardiovascular autonomic dysfunction between DLB and PD.
  • To investigate the underlying mechanisms of autonomic dysfunction in DLB.

Main Methods:

  • Utilized meta-iodobenzylguanidine ((123)I-MIBG) scintigraphy and hemodynamic autonomic function testing (Valsalva maneuver).
  • Included 27 patients with DLB, 46 with PD, and 20 healthy controls.

Main Results:

  • Reduced (123)I-MIBG uptake in DLB compared to PD and controls.
  • DLB exhibited decreased baroreceptor reflex and blunted SBP responses.
  • DLB showed significantly lower SBP responses and plasma norepinephrine levels than PD and controls, suggesting more severe sympathetic denervation.

Conclusions:

  • Cardiovascular autonomic dysfunction is more pronounced in DLB than in PD.
  • The primary cause in DLB is typically postganglionic sympathetic nervous dysfunction.
  • A subset of DLB patients may experience dysautonomia due to preganglionic dysfunction.
Abstract

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.